Semaglutide
Synthetic 31-amino-acid analog of human GLP-1, modified for extended half-life via fatty acid conjugation that promotes albumin binding. Selectively binds and activates the GLP-1 receptor, regulating glucose-dependent insulin secretion, gastric emptying, and central appetite signaling.